HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention
- PMID: 17694074
- DOI: 10.1038/sj.onc.1210599
HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention
Abstract
Acetylation of the epsilon-amino group of a lysine residue was first discovered with histones in 1968, but the responsible enzymes, histone acetyltransferases and deacetylases, were not identified until the mid-1990s. In the past decade, knowledge about this modification has exploded, with targets rapidly expanding from histones to transcription factors and other nuclear proteins, and then to cytoskeleton, metabolic enzymes, and signaling regulators in the cytoplasm. Thus, protein lysine acetylation has emerged as a major post-translational modification to rival phosphorylation. In this issue of Oncogene, 19 articles review various aspects of the enzymes governing lysine acetylation, especially about their intimate links to cancer. To introduce the articles, we highlight here four central themes: (i) multisubunit enzymatic complexes; (ii) non-histone substrates in diverse cellular processes; (iii) interplay of lysine acetylation with other regulatory mechanisms, such as noncoding RNA-mediated gene silencing and activation; and (iv) novel therapeutic strategies and preventive measures to combat cancer and other human diseases.
Similar articles
-
Regulation of protein turnover by acetyltransferases and deacetylases.Biochimie. 2008 Feb;90(2):306-12. doi: 10.1016/j.biochi.2007.06.009. Epub 2007 Jul 1. Biochimie. 2008. PMID: 17681659 Review.
-
Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.Oncogene. 2007 Aug 13;26(37):5528-40. doi: 10.1038/sj.onc.1210619. Oncogene. 2007. PMID: 17694092 Review.
-
Acetylation of proteins as novel target for antitumor therapy: review article.Amino Acids. 2004 Jul;26(4):435-41. doi: 10.1007/s00726-004-0087-3. Epub 2004 Jun 11. Amino Acids. 2004. PMID: 15290351 Review.
-
Acetylation of non-histone proteins modulates cellular signalling at multiple levels.Int J Biochem Cell Biol. 2009 Jan;41(1):185-98. doi: 10.1016/j.biocel.2008.08.027. Epub 2008 Sep 2. Int J Biochem Cell Biol. 2009. PMID: 18804549 Review.
-
Small molecule modulators in epigenetics: implications in gene expression and therapeutics.Subcell Biochem. 2007;41:397-428. Subcell Biochem. 2007. PMID: 17484138 Review.
Cited by
-
The significance of epigenetic alterations in lung carcinogenesis.Mol Biol Rep. 2013 Jan;40(1):309-25. doi: 10.1007/s11033-012-2063-4. Epub 2012 Oct 20. Mol Biol Rep. 2013. PMID: 23086271 Free PMC article. Review.
-
Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging.Neurobiol Dis. 2016 Jan;85:245-253. doi: 10.1016/j.nbd.2015.03.028. Epub 2015 Apr 2. Neurobiol Dis. 2016. PMID: 25843666 Free PMC article. Review.
-
Epigenetics and its role in effecting agronomical traits.Front Plant Sci. 2022 Aug 15;13:925688. doi: 10.3389/fpls.2022.925688. eCollection 2022. Front Plant Sci. 2022. PMID: 36046583 Free PMC article. Review.
-
Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells.Cancer Cell Int. 2013 Apr 4;13(1):32. doi: 10.1186/1475-2867-13-32. Cancer Cell Int. 2013. PMID: 23556431 Free PMC article.
-
Building a better hormone therapy? How understanding the rapid effects of sex steroid hormones could lead to new therapeutics for age-related memory decline.Behav Neurosci. 2012 Feb;126(1):29-53. doi: 10.1037/a0026660. Behav Neurosci. 2012. PMID: 22289043 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous